TOP-T5

N/A

Report date: 2025/01/26 15:35:29
NME

Base Information

Drug NameTOP-T5
Drug Alias Namedual guanylate cyclase stimulator/PDE5 inhibitor (Topadur Pharma)TOP-T5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitorsGuanylate cyclase stimulants
TargetsGuanylate cyclasePhosphodiesterase 5A
Therapy Area/IndicationsGeographic AtrophyDiabetic RetinopathyGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTopadur Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesTopadur Pharma AG
Inactive CompaniesN/A
Active IndicationsGeographic AtrophyDiabetic RetinopathyGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A